{"success":true,"data":{"pressRelease":{"id":"61799","rtpr_id":"nGNX4hnzZ6","ticker":"NNOX","exchange":"NASDAQ","all_tickers":["NNOX"],"title":"Nanox to Report First Quarter 2026 Financial Results on June 25, 2026","author":"Globe Newswire","published_at":"2026-06-11T20:01:00.134Z","article_body":"PETACH TIKVA, Israel, June 11, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD\n(\"Nanox\" or the \"Company\", Nasdaq: NNOX), an innovative medical imaging\ntechnology company, today announced that it will report its financial results\nfor the quarter ended March 31, 2026, before market open on Thursday, June 25,\n2026. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran\nDaniel, Chief Financial Officer, will host a conference call to review these\nresults and provide a business update beginning at 8:30 a.m. ET.\n\nInterested parties may register for the conference call using the following\nlink: Nanox Q1 2026 Call Registration\n(https://www.globenewswire.com/Tracker?data=0WPjSw3S3c8XKnR5Cf7a0vzN4q8qB-mk4VO1HVWVmMpsoM36En_VdJqEMILskTfA-Fq_LUKVJ29FGB6LU4K66kXywQzIobbxgPqlZKNsegTNpY7elS0QCg-od5dIkaWgzvRfWXBv_ftyj3-CidtV2nygUa0PGrSYjozEC7cfU_7seYkSmK5mM2m71w0PS-ho)\n\nThe live webcast of the conference call may be accessed by using the following\nlink: Nanox Q1 2026 Webcast\n(https://www.globenewswire.com/Tracker?data=0WPjSw3S3c8XKnR5Cf7a0uA1P8aJPh_5sPBSnAvBGx5y0A85ob_SeRklteP-WjH76EXqVDgsHK9XRHeu9BKn0Ytpxs_CaEPpNDg0gDpaN45Mepj4IvcEJWGQzy6I-2O5)\n\nThe webcast link will also be posted in the Investor Relations section of the\nNanox website at Events and Presentations\n(https://www.globenewswire.com/Tracker?data=NaZ1ydpdz02BojpIEoc8TkdpqWptUNvUIFUrnQFg2MS0gTtKW9Azu-j-mcvrvvX-j_7GEtCzK3Qr3mZqr4a9LCH1xaIMDxwegOqaHZ9jxd_6to0bnAICUSUVa0ISNWUGxH2VeUR1rdCNrlHJh0SsjxXeqsv1a3fEKTjxoGkddAc1Mh8xSCaHtG5SpS-GqHuRotNBMQO0r3WyERvNxbGNFYAWcNvyTtuySpp2E7yXh625Q3CHwG_CWNyD0u4UmO4epjUhzAe-iIHIIQPCBBGsSOgGEpGqHdf4k-d6ET0CnOMp-ex8qvZXnAec4r0qFoQU-BtHeqtsWjxKM_hTuwIHqt7dS39bZhAnnsA1KgqMqU4js-DzjGvD_SBexaoP5ZLCaOer-JlSwDqCvobfOmTgLJG5OBoElFtSwQZdOQe6IUCcwrBiqpKMr05CHqn7kIIhFwy20S0mJObBOJ7AdsCIKQUi32O89sBEMPGAIsdSsjmgv9gIBSadSx9dknfYO2lGBRrCD4CXX7lWBLjnOR3TfUNFaW53weXPYs0GpKJKlDZakGuRpuaVXttK0QEhlnn1jhAS6mADHh_FZDIQJqWvzICGTw9bj0Hmgq-67mhY45lKiEw6rAo0HMRBmRA7ghMUYOgvChv8pVfvHb6z2reSS19XkkazszyVMAjG4HdcESHJJ9YO6hpbXdy6j2ERJsvPBoo7S53y6LcR7NARN3CFrPmD3Yr_3zIIgNA26XN-rBNCnFiKM3kfS-ZmFxd1bfm1qITk3V5T7DIiWXYX57cX02TFWAV7COE7lY5jEK7ZMdpJDkulMzzgVd0o_UAghUQew7XmcQwYcMQMsMuUPLvAoDfNjBDYD2nJ-WeZiXTMfTFT1DsfHDslHDKJJjdhmzo0g0fLjUvmnZAUrj3D0FMhn73nTQkRtOt5jZUYLlkzllOZJUTyBUAVvVG5-QUoZaJjm-w8FI5Vtqi5C7GTGVmifET-IvA7_M-PJRyip3E8sCYACBGQ6wTJt2IuGs_bOvWTK1-lgl2cFP_2MxFRHwENnqRqCYrP9R_Um7AhxBRNORQ144oYu81ZEiK7vQwZoVpJK3xE5Snssad3-_JpfqxGcP1HVlxX9KW2qtDrYKCp5TrIHqvJ_gUlamsGNs1P7BJe9we55AdRes-DbfNIOp7x6WzcD3jXk1RDgdkN1I6AeWw_EfEh-ujnhmt-CMQGBau0v6rg2f3wGplah25KFHF3hBElk09RN2PDvPEoUe14y-XupZkyoUodbJ9khFomMG_ud6V9jUq8NPs5Wuwq7Y0IHcTnyM7BiBAgTYJeqO3-v6HAmL0ft68iLtSvt1-xJqBqx6mknyuUmrxv9XsJ1DTKcWlCo_sAamHTSe0mPj5aRs5JqZea6zoxqiuzIw-IHM5gE_V9GLUMyE24Nl_QVqEc2AUQxj1gT87Tk7CCBrXJ6ALksSKlLjyDynlaa2U5ctK7MBWiMBz-25xGnpS6b80fVV6n77Oe5QP3mMQP7-AHS5ydtbVzI30M_liYrdsrAXYb4hVRzR-uj0MfKBYnHnWJSfOuSUNHEX6SfVqm9sZ_A5TO4sKSHkgoNtAbPIC9sqY4M0fZtMe2EbAXYlfPJbYR9nIAFfU7J7sLSfdhq6QFtJkff2gjlX_v6WmmJFduQoGSn9kFJrH-HX4Mnr2-BLA6a4faCpSGTx8cabwOnJBiqX0fWd4b_adn-j4RWOZ30IfqNvYJiR4qkVDc5Qa5WLSU1o6NWBFbTTo1oxj485i9shwxPGbXFYtpk2BHe2gOrxioDkdcJc0upz6mJnVDHrDyQD1Zjg_2VoWOu_oRjleP5MhJJFI9kHCvzNm4MmQWQMWnU6KrS6OZez0KRlDEkOp5Xexi3WC5eg0wGzZRFkFA_bAQH-Yt7D7TbTOS3R9LFLcp6I_ktLlk8L8v9iYUIXNemDaijUypvfxXhd0--Ga2DQPmD2mI45NbVRBUwYHRmTS4). \n\nAbout Nanox\n\nNanox (NASDAQ: NNOX) is focused on driving the world’s transition to\npreventive health care by delivering an integrated, end-to-end medical imaging\nand healthcare services platform.\n\nNanox combines affordable imaging hardware, advanced AI-based solutions,\ncloud-based software, access to remote radiology, health IT solutions, and a\nmarketplace to enable earlier detection, improved clinical efficiency, and\nbroader access to care.\n\nNanox’s vision is to expand the reach of medical imaging both within and\nbeyond traditional hospital settings by providing a seamless solution from\nscan to interpretation and beyond. By leveraging proprietary digital X-ray\ntechnology, AI-driven analytics, and a clinically driven approach, Nanox aims\nto enhance the efficiency of routine imaging workflows, support early\ndetection of disease, and improve patient outcomes.\n\nThe Nanox ecosystem includes Nanox.ARC, a cost-effective, 3D multi-source\ndigital tomosynthesis imaging system designed for ease of use and scalability;\nNanox.AI, a suite of AI-based algorithms that augment the interpretation of\nroutine CT imaging to identify early signs often associated with chronic\ndisease; Nanox.CLOUD, a cloud-based platform for secure data management,\nstorage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD\nHoldings, which provide access to remote radiology and cardiology experts and\ncomprehensive teleradiology services; and Nanox Health IT, which combines deep\nhealthcare IT expertise with leading technology partners to deliver RIS, PACS,\nAI, dictation, and secure infrastructure solutions that streamline workflows\nand support safer, more efficient care delivery.\n\nBy integrating imaging technology, AI, cloud infrastructure, clinical\nexpertise, a marketplace, and health information technology, Nanox seeks to\nlower barriers to adoption, improve utilization, and advance preventive care\nworldwide. For more information, please visit www.nanox.vision\n\nForward-Looking Statements\n\nThis press release may contain forward-looking statements that are subject to\nrisks and uncertainties. All statements that are not historical facts\ncontained in this press release are forward-looking statements. Such\nstatements include, but are not limited to, any statements relating to the\ninitiation, timing, progress and results of the Company’s research and\ndevelopment, manufacturing, and commercialization activities with respect to\nits X-ray source technology and the Nanox.ARC, the ability to realize the\nexpected benefits of its recent acquisitions and the projected business\nprospects of the Company and the acquired companies. In some cases, you can\nidentify forward-looking statements by terminology such as “can,”\n“might,” “believe,” “may,” “estimate,” “continue,”\n“anticipate,” “intend,” “should,” “plan,” “should,”\n“could,” “expect,” “predict,” “potential,” or the negative of\nthese terms or other similar expressions. Forward-looking statements are based\non information the Company has when those statements are made or\nmanagement’s good faith belief as of that time with respect to future\nevents and are subject to risks and uncertainties that could cause actual\nperformance or results to differ materially from those expressed in or\nsuggested by the forward-looking statements. Factors that could cause actual\nresults to differ materially from those currently anticipated include: risks\nrelated to (i) Nanox’s ability to complete development of the Nanox System;\n(ii) Nanox’s ability to successfully demonstrate the feasibility of its\ntechnology for commercial applications; (iii) Nanox’s history of recurring\nlosses and negative cash flows from operating activities, significant future\ncommitments and the uncertainty regarding the adequacy of Nanox’s liquidity\nto pursue its complete business objectives, and substantial doubt regarding\nits ability to continue as a going concern; (iv) Nanox’s expectations\nregarding the necessity of, timing of filing for, and receipt and maintenance\nof, regulatory clearances or approvals regarding its technology, the Nanox.ARC\nand Nanox.CLOUD from regulatory agencies worldwide and its ongoing compliance\nwith applicable quality standards and regulatory requirements; (v) Nanox’s\nability to realize the anticipated benefits of the acquisitions, which may be\naffected by, among other things, competition, brand recognition, the ability\nof the acquired companies to grow and manage growth profitably and retain\ntheir key employees; (vi) Nanox’s ability to enter into and maintain\ncommercially reasonable arrangements with third-party manufacturers and\nsuppliers to manufacture the Nanox.ARC; (vii) the market acceptance of the\nNanox System and the proposed pay-per-scan business model; (viii) Nanox’s\nexpectations regarding collaborations with third-parties and their potential\nbenefits; (ix) Nanox’s ability to conduct business globally; (x) changes in\nglobal, political, economic, business, competitive, market and regulatory\nforces; (xi) risks related to the current war between Israel and Hamas and any\nworsening of the situation in Israel; (xii) risks related to business\ninterruptions resulting from the COVID-19 pandemic or similar public health\ncrises, among other things; and (xiii) potential litigation associated with\nour transactions.\n\nFor a discussion of other risks and uncertainties, and other important\nfactors, any of which could cause Nanox’s actual results to differ from\nthose contained in the Forward-Looking Statements, see the section titled\n“Risk Factors” in Nanox’s Annual Report on Form 20-F for the year ended\nDecember 31, 2025, and subsequent filings with the U.S. Securities and\nExchange Commission. The reader should not place undue reliance on any\nforward-looking statements included in this press release. Except as required\nby law, Nanox undertakes no obligation to update publicly any forward-looking\nstatements after the date of this press release to conform these statements to\nactual results or to changes in the Company’s expectations.\n\nContacts\n\nInvestor Contact\nMike Cavanaugh\nICR Healthcare\nmike.cavanaugh@icrhealthcare.com\n\nMedia Contact\nICR Healthcare\nNanoxPR@icrinc.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/57c1ffd6-84b3-46b9-b9b3-76666e6ba5a2)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX4hnzZ6","title":"Nanox to Report First Quarter 2026 Financial Results on June 25, 2026","author":"Globe Newswire","ticker":"NNOX","created":"2026-06-11T20:01:00.134Z","tickers":["NNOX"],"exchange":"NASDAQ","article_body":"PETACH TIKVA, Israel, June 11, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD\n(\"Nanox\" or the \"Company\", Nasdaq: NNOX), an innovative medical imaging\ntechnology company, today announced that it will report its financial results\nfor the quarter ended March 31, 2026, before market open on Thursday, June 25,\n2026. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran\nDaniel, Chief Financial Officer, will host a conference call to review these\nresults and provide a business update beginning at 8:30 a.m. ET.\n\nInterested parties may register for the conference call using the following\nlink: Nanox Q1 2026 Call Registration\n(https://www.globenewswire.com/Tracker?data=0WPjSw3S3c8XKnR5Cf7a0vzN4q8qB-mk4VO1HVWVmMpsoM36En_VdJqEMILskTfA-Fq_LUKVJ29FGB6LU4K66kXywQzIobbxgPqlZKNsegTNpY7elS0QCg-od5dIkaWgzvRfWXBv_ftyj3-CidtV2nygUa0PGrSYjozEC7cfU_7seYkSmK5mM2m71w0PS-ho)\n\nThe live webcast of the conference call may be accessed by using the following\nlink: Nanox Q1 2026 Webcast\n(https://www.globenewswire.com/Tracker?data=0WPjSw3S3c8XKnR5Cf7a0uA1P8aJPh_5sPBSnAvBGx5y0A85ob_SeRklteP-WjH76EXqVDgsHK9XRHeu9BKn0Ytpxs_CaEPpNDg0gDpaN45Mepj4IvcEJWGQzy6I-2O5)\n\nThe webcast link will also be posted in the Investor Relations section of the\nNanox website at Events and Presentations\n(https://www.globenewswire.com/Tracker?data=NaZ1ydpdz02BojpIEoc8TkdpqWptUNvUIFUrnQFg2MS0gTtKW9Azu-j-mcvrvvX-j_7GEtCzK3Qr3mZqr4a9LCH1xaIMDxwegOqaHZ9jxd_6to0bnAICUSUVa0ISNWUGxH2VeUR1rdCNrlHJh0SsjxXeqsv1a3fEKTjxoGkddAc1Mh8xSCaHtG5SpS-GqHuRotNBMQO0r3WyERvNxbGNFYAWcNvyTtuySpp2E7yXh625Q3CHwG_CWNyD0u4UmO4epjUhzAe-iIHIIQPCBBGsSOgGEpGqHdf4k-d6ET0CnOMp-ex8qvZXnAec4r0qFoQU-BtHeqtsWjxKM_hTuwIHqt7dS39bZhAnnsA1KgqMqU4js-DzjGvD_SBexaoP5ZLCaOer-JlSwDqCvobfOmTgLJG5OBoElFtSwQZdOQe6IUCcwrBiqpKMr05CHqn7kIIhFwy20S0mJObBOJ7AdsCIKQUi32O89sBEMPGAIsdSsjmgv9gIBSadSx9dknfYO2lGBRrCD4CXX7lWBLjnOR3TfUNFaW53weXPYs0GpKJKlDZakGuRpuaVXttK0QEhlnn1jhAS6mADHh_FZDIQJqWvzICGTw9bj0Hmgq-67mhY45lKiEw6rAo0HMRBmRA7ghMUYOgvChv8pVfvHb6z2reSS19XkkazszyVMAjG4HdcESHJJ9YO6hpbXdy6j2ERJsvPBoo7S53y6LcR7NARN3CFrPmD3Yr_3zIIgNA26XN-rBNCnFiKM3kfS-ZmFxd1bfm1qITk3V5T7DIiWXYX57cX02TFWAV7COE7lY5jEK7ZMdpJDkulMzzgVd0o_UAghUQew7XmcQwYcMQMsMuUPLvAoDfNjBDYD2nJ-WeZiXTMfTFT1DsfHDslHDKJJjdhmzo0g0fLjUvmnZAUrj3D0FMhn73nTQkRtOt5jZUYLlkzllOZJUTyBUAVvVG5-QUoZaJjm-w8FI5Vtqi5C7GTGVmifET-IvA7_M-PJRyip3E8sCYACBGQ6wTJt2IuGs_bOvWTK1-lgl2cFP_2MxFRHwENnqRqCYrP9R_Um7AhxBRNORQ144oYu81ZEiK7vQwZoVpJK3xE5Snssad3-_JpfqxGcP1HVlxX9KW2qtDrYKCp5TrIHqvJ_gUlamsGNs1P7BJe9we55AdRes-DbfNIOp7x6WzcD3jXk1RDgdkN1I6AeWw_EfEh-ujnhmt-CMQGBau0v6rg2f3wGplah25KFHF3hBElk09RN2PDvPEoUe14y-XupZkyoUodbJ9khFomMG_ud6V9jUq8NPs5Wuwq7Y0IHcTnyM7BiBAgTYJeqO3-v6HAmL0ft68iLtSvt1-xJqBqx6mknyuUmrxv9XsJ1DTKcWlCo_sAamHTSe0mPj5aRs5JqZea6zoxqiuzIw-IHM5gE_V9GLUMyE24Nl_QVqEc2AUQxj1gT87Tk7CCBrXJ6ALksSKlLjyDynlaa2U5ctK7MBWiMBz-25xGnpS6b80fVV6n77Oe5QP3mMQP7-AHS5ydtbVzI30M_liYrdsrAXYb4hVRzR-uj0MfKBYnHnWJSfOuSUNHEX6SfVqm9sZ_A5TO4sKSHkgoNtAbPIC9sqY4M0fZtMe2EbAXYlfPJbYR9nIAFfU7J7sLSfdhq6QFtJkff2gjlX_v6WmmJFduQoGSn9kFJrH-HX4Mnr2-BLA6a4faCpSGTx8cabwOnJBiqX0fWd4b_adn-j4RWOZ30IfqNvYJiR4qkVDc5Qa5WLSU1o6NWBFbTTo1oxj485i9shwxPGbXFYtpk2BHe2gOrxioDkdcJc0upz6mJnVDHrDyQD1Zjg_2VoWOu_oRjleP5MhJJFI9kHCvzNm4MmQWQMWnU6KrS6OZez0KRlDEkOp5Xexi3WC5eg0wGzZRFkFA_bAQH-Yt7D7TbTOS3R9LFLcp6I_ktLlk8L8v9iYUIXNemDaijUypvfxXhd0--Ga2DQPmD2mI45NbVRBUwYHRmTS4). \n\nAbout Nanox\n\nNanox (NASDAQ: NNOX) is focused on driving the world’s transition to\npreventive health care by delivering an integrated, end-to-end medical imaging\nand healthcare services platform.\n\nNanox combines affordable imaging hardware, advanced AI-based solutions,\ncloud-based software, access to remote radiology, health IT solutions, and a\nmarketplace to enable earlier detection, improved clinical efficiency, and\nbroader access to care.\n\nNanox’s vision is to expand the reach of medical imaging both within and\nbeyond traditional hospital settings by providing a seamless solution from\nscan to interpretation and beyond. By leveraging proprietary digital X-ray\ntechnology, AI-driven analytics, and a clinically driven approach, Nanox aims\nto enhance the efficiency of routine imaging workflows, support early\ndetection of disease, and improve patient outcomes.\n\nThe Nanox ecosystem includes Nanox.ARC, a cost-effective, 3D multi-source\ndigital tomosynthesis imaging system designed for ease of use and scalability;\nNanox.AI, a suite of AI-based algorithms that augment the interpretation of\nroutine CT imaging to identify early signs often associated with chronic\ndisease; Nanox.CLOUD, a cloud-based platform for secure data management,\nstorage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD\nHoldings, which provide access to remote radiology and cardiology experts and\ncomprehensive teleradiology services; and Nanox Health IT, which combines deep\nhealthcare IT expertise with leading technology partners to deliver RIS, PACS,\nAI, dictation, and secure infrastructure solutions that streamline workflows\nand support safer, more efficient care delivery.\n\nBy integrating imaging technology, AI, cloud infrastructure, clinical\nexpertise, a marketplace, and health information technology, Nanox seeks to\nlower barriers to adoption, improve utilization, and advance preventive care\nworldwide. For more information, please visit www.nanox.vision\n\nForward-Looking Statements\n\nThis press release may contain forward-looking statements that are subject to\nrisks and uncertainties. All statements that are not historical facts\ncontained in this press release are forward-looking statements. Such\nstatements include, but are not limited to, any statements relating to the\ninitiation, timing, progress and results of the Company’s research and\ndevelopment, manufacturing, and commercialization activities with respect to\nits X-ray source technology and the Nanox.ARC, the ability to realize the\nexpected benefits of its recent acquisitions and the projected business\nprospects of the Company and the acquired companies. In some cases, you can\nidentify forward-looking statements by terminology such as “can,”\n“might,” “believe,” “may,” “estimate,” “continue,”\n“anticipate,” “intend,” “should,” “plan,” “should,”\n“could,” “expect,” “predict,” “potential,” or the negative of\nthese terms or other similar expressions. Forward-looking statements are based\non information the Company has when those statements are made or\nmanagement’s good faith belief as of that time with respect to future\nevents and are subject to risks and uncertainties that could cause actual\nperformance or results to differ materially from those expressed in or\nsuggested by the forward-looking statements. Factors that could cause actual\nresults to differ materially from those currently anticipated include: risks\nrelated to (i) Nanox’s ability to complete development of the Nanox System;\n(ii) Nanox’s ability to successfully demonstrate the feasibility of its\ntechnology for commercial applications; (iii) Nanox’s history of recurring\nlosses and negative cash flows from operating activities, significant future\ncommitments and the uncertainty regarding the adequacy of Nanox’s liquidity\nto pursue its complete business objectives, and substantial doubt regarding\nits ability to continue as a going concern; (iv) Nanox’s expectations\nregarding the necessity of, timing of filing for, and receipt and maintenance\nof, regulatory clearances or approvals regarding its technology, the Nanox.ARC\nand Nanox.CLOUD from regulatory agencies worldwide and its ongoing compliance\nwith applicable quality standards and regulatory requirements; (v) Nanox’s\nability to realize the anticipated benefits of the acquisitions, which may be\naffected by, among other things, competition, brand recognition, the ability\nof the acquired companies to grow and manage growth profitably and retain\ntheir key employees; (vi) Nanox’s ability to enter into and maintain\ncommercially reasonable arrangements with third-party manufacturers and\nsuppliers to manufacture the Nanox.ARC; (vii) the market acceptance of the\nNanox System and the proposed pay-per-scan business model; (viii) Nanox’s\nexpectations regarding collaborations with third-parties and their potential\nbenefits; (ix) Nanox’s ability to conduct business globally; (x) changes in\nglobal, political, economic, business, competitive, market and regulatory\nforces; (xi) risks related to the current war between Israel and Hamas and any\nworsening of the situation in Israel; (xii) risks related to business\ninterruptions resulting from the COVID-19 pandemic or similar public health\ncrises, among other things; and (xiii) potential litigation associated with\nour transactions.\n\nFor a discussion of other risks and uncertainties, and other important\nfactors, any of which could cause Nanox’s actual results to differ from\nthose contained in the Forward-Looking Statements, see the section titled\n“Risk Factors” in Nanox’s Annual Report on Form 20-F for the year ended\nDecember 31, 2025, and subsequent filings with the U.S. Securities and\nExchange Commission. The reader should not place undue reliance on any\nforward-looking statements included in this press release. Except as required\nby law, Nanox undertakes no obligation to update publicly any forward-looking\nstatements after the date of this press release to conform these statements to\nactual results or to changes in the Company’s expectations.\n\nContacts\n\nInvestor Contact\nMike Cavanaugh\nICR Healthcare\nmike.cavanaugh@icrhealthcare.com\n\nMedia Contact\nICR Healthcare\nNanoxPR@icrinc.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/57c1ffd6-84b3-46b9-b9b3-76666e6ba5a2)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-06-11T20:01:00.185007442Z","server_sent_at_ms":1781208060185},"received_at":"2026-06-11T20:01:00.300Z","source_url":null},"analysis":{"id":"51224","press_release_id":"61799","analysis_json":{"industry":{"label":"Health Care Equipment","sector":"Health Care"},"redFlags":["Forward-looking statements disclose 'substantial doubt regarding its ability to continue as a going concern'","Forward-looking statements cite 'history of recurring losses and negative cash flows'"],"eventType":"earnings","narrative":"Nanox will report first quarter 2026 financial results for the period ended March 31, 2026, on June 25, 2026, before market open.\n\nCEO Erez Meltzer and CFO Ran Daniel will host a conference call at 8:30 a.m. ET to review the results and provide a business update.\n\nThe release contains no financial figures or guidance, serving only to announce the reporting date and call logistics.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine earnings date announcement for NNOX; no material data to trade on."},"keyFigures":{},"quotedText":"Nanox ... today announced that it will report its financial results for the quarter ended March 31, 2026, before market open on Thursday, June 25, 2026.","namedEntities":{"people":[{"name":"Erez Meltzer","role":"Chief Executive Officer and Acting Chairman"},{"name":"Ran Daniel","role":"Chief Financial Officer"},{"name":"Mike Cavanaugh","role":"Investor Contact"}],"products":["Nanox.ARC","Nanox.AI","Nanox.CLOUD","Nanox.MARKETPLACE","USARAD Holdings","Nanox Health IT"],"companies":[{"name":"NANO-X IMAGING LTD","ticker":"NNOX"},{"name":"ICR Healthcare","relationship":"investor relations firm"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"This is a standard earnings date announcement with no financial results, guidance, or material operational updates disclosed. It is purely informational regarding the timing of the upcoming report."},"tickerRelevance":{"others":[],"primary":"NNOX"},"globalImportance":15,"audienceRelevance":20,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"earnings-date-announcement","householdBrandBoost":0,"marketCapAdjustment":"low"}},"event_type":"earnings","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Nanox will report first quarter 2026 financial results for the period ended March 31, 2026, on June 25, 2026, before market open.\n\nCEO Erez Meltzer and CFO Ran Daniel will host a conference call at 8:30 a.m. ET to review the results and provide a business update.\n\nThe release contains no financial figures or guidance, serving only to announce the reporting date and call logistics.","key_figures":{},"named_entities":{"people":[{"name":"Erez Meltzer","role":"Chief Executive Officer and Acting Chairman"},{"name":"Ran Daniel","role":"Chief Financial Officer"},{"name":"Mike Cavanaugh","role":"Investor Contact"}],"products":["Nanox.ARC","Nanox.AI","Nanox.CLOUD","Nanox.MARKETPLACE","USARAD Holdings","Nanox Health IT"],"companies":[{"name":"NANO-X IMAGING LTD","ticker":"NNOX"},{"name":"ICR Healthcare","relationship":"investor relations firm"}],"dollarAmounts":[]},"model_name":"qwen3_6_27b_awq","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-06-11T20:02:51.008Z","global_importance":15,"audience_relevance":20,"importance_components":{"tickerTier":"small-cap","eventGravity":"earnings-date-announcement","householdBrandBoost":0,"marketCapAdjustment":"low"}},"durationMs":50415,"modelName":"george-droid-qwen-72b"}}